Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term human albumin in decompensated cirrhosis with ascites
2016-001789-28Phase 3Completed
- Sponsor
- Instituto Grifols
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of albumin (human) in decompensated cirrhosis and ascites (2 arms), sponsored by Instituto Grifols. Primary endpoint: 1-year transplant-free survival. Started Nov 2017; status: completed.
02
Drugs
albumin (human)
03
Conditions
decompensated cirrhosisascites
Beyond the preview
Go deeper on 2016-001789-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001789-28.